Skip to search formSkip to main contentSkip to account menu

FND Regimen

Known as: FMD Regimen, Fludarabine-Novantrone-Dexamethasone Regimen 
A regimen consisting of fludarabine, mitoxantrone and dexamethasone used to treat indolent non-Hodgkin's lymphoma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Objective:To study the efficacy of rituximab(R) plus FND chemotherapy and rituximab plus CHOP chemotherapy for MALT lymphoma… 
2009
2009
Se efectuó el engorde de 120 bovinos (296 ± 6,9 kg) machos cruzados de Cebú durante 120 días divididos en tres tratamientos… 
2007
2007
Objective To discuss the therapeutic effect and toxicity of FMD regimen in initial un- treated patients with indolent non-Hodgkin… 
2004
2004
SummaryAlthough a number of investigators have established that mitoxantrone (Novantrone®; dihydroxyanthracenedione) inhibits RNA… 
2004
2004
SummaryForty-nine patients with histologically confirmed primary liver cancer have been entered on phase II trials of… 
2004
2004
Vinorelbine (Navelbine®) is a unique semi-synthetic vinca-alkaloid with a favorable safety profile that has demonstrated… 
2004
2004
SummaryNineteen patients with advanced, previously treated breast cancer received treatment with vincristine 2 mg i.v., mitomycin… 
2004
2004
SummaryA phase II study of mitoxantrone (Novantrone®; dihydroxyanthracenedione) was conducted in 35 patients (22 male: 13 female… 
1996
1996
The adenine nucleoside analogue, fludarabine phosphate, in combination with cytosine-arabinoside (Ara-C) and granulocyte-colony…